搜索临床试验以:NNC172-2021
总计741个结果
-
Precigen, IncNational Cancer Institute (NCI)主动,不招人
-
Vascular Biogenics Ltd. operating as VBL Therapeutics完全的
-
Suzhou Connect Biopharmaceuticals, Ltd.主动,不招人
-
Stanford UniversityNational Institute of Allergy and Infectious Diseases (NIAID)完全的
-
Orion Corporation, Orion PharmaEndo Pharmaceuticals完全的
-
Intellia TherapeuticsRegeneron Pharmaceuticals招聘中转甲状腺素蛋白淀粉样变性 (ATTR) 伴心肌病美国, 澳大利亚, 英国, 新西兰, 加拿大
-
Novo Nordisk A/S完全的
-
Chase Pharmaceuticals Corporation, an affiliate...完全的
-
Chase Pharmaceuticals Corporation, an affiliate...完全的
-
Proteon TherapeuticsUniversity of California, San Francisco完全的
-
Italian Sarcoma GroupAssociazione Italiana Ematologia Oncologia Pediatrica招聘中
-
National Institute on Drug Abuse (NIDA)Technical Resources International, Inc.; Promentis Pharmaceuticals, Inc.; Altasciences Company...尚未招聘